References
- Seizinger B R, Rouleau G A, Ozelius L J, et al. Von Hippel-Lindau disease maps to chromosome 3 associated with renal cell carcinoma. Nature 1988; 332: 268–269
- Richards F. Molecular pathology of von Hippel-Lindau disease and the VHL tumour suppressor gene. Expert Rev Mol Med 2001; 19(March)1–27, http://www.expertreviews.org/01002654h.htm (accessed July 2007)
- Collins E. Intra-ocular growth (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans Opthalmol Soc UK 1894; 14: 141–149
- Lamiell J M, Salazar F G, Hsia Y E. Von Hippel-Lindau disease: affecting 43 members of a single kindred. Medicine 1989; 68: 1–29
- Bohling T, Plate K H, Haltia M J, . Von Hippel-Lindau disease and capillary haemangioblastoma. Pathology and Genetics of Tumors of the Nervous System. WHO Classification of Tumours2nd ed., P Kleihues, W K Cavanee, et al. IARC Press, Lyon 2000; 223–226
- Roy S, Chu A, Trojanowski J Q, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish haemangioblastomas from renal cell carcinomas. Acta Neuropathol (Berl) 2005; 109: 497–502
- Giannini C, Scheithauer B W, Hellbusch L C, et al. Peripheral nerve haemangioblastoma. Mod Pathol 1998; 11: 999–1004
- Fanburg-Smith J C, Gyure K A, Michal M, et al. Retroperitoneal peripheral haemangioblastoma: a case report and review of the literature. Ann Diagn Pathol 2000; 4: 81–87
- Burns C, Levine P H, Reichman H, et al. Case report: adrenal hemangioblastoma in Von Hippel-Lindau disease as a cause of secondary erythrocytosis. Am J Med Sci 1987; 293: 119–121